All In MedTech

FDA Clearance Tracker · P150040-S008

VisuMax Femtosecond Laser

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 19, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 19, 2021

Approved

Time to decision

92 days

Received Nov 19, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P150040-S008
Device name
VisuMax Femtosecond Laser
Applicant location
Dublin, CA
Received
Nov 19, 2020
Decided
Feb 19, 2021
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P150040

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code OTL

FDA's approval statement

As written in FDA's record.

Approval of obsolescence and life-cycle changes of hardware, software, and electronics.

Source documents

Other decisions for Carl Zeiss Meditec, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.